Viewing Study NCT02938793

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-02-23 @ 8:09 PM
Study NCT ID: NCT02938793
Status: TERMINATED
Last Update Posted: 2025-09-23
First Post: 2016-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors
Sponsor: Prisma Health-Upstate
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Rare Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer, malignancy View